SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-24-000091
Filing Date
2024-08-01
Accepted
2024-08-01 06:07:59
Documents
84
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20240630.htm   iXBRL 10-Q 1063679
2 EX-31.1 auph-2024q2exx311.htm EX-31.1 10868
3 EX-31.2 auph-2024q2exx312.htm EX-31.2 11010
4 EX-32.1 auph-2024q2exx321.htm EX-32.1 5335
5 EX-32.2 auph-2024q2exx322.htm EX-32.2 5343
  Complete submission text file 0001600620-24-000091.txt   6152428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20240630.xsd EX-101.SCH 43664
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20240630_cal.xml EX-101.CAL 75736
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20240630_def.xml EX-101.DEF 168667
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20240630_lab.xml EX-101.LAB 504634
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20240630_pre.xml EX-101.PRE 351593
87 EXTRACTED XBRL INSTANCE DOCUMENT auph-20240630_htm.xml XML 892864
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 241163981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)